Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study investigating local delivery of GM-CSF via bronchoscopy to treat autoimmune pulmonary alveolar proteinosis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Jiuwu Bai | Conditions: Pulmonary Alveolar Proteinosis | Phase 2 | Status: NOT_YET_RECRUITING